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An experimental model of lacunar infarction:
Embolization of microthrombi
Joseph H. Rapp, MD, Kelsy Hollenbeck, BS, and Xian Mang Pan, MD, San Francisco, Calif
Objectives: Microthrombi are undoubtedly the most common embolic material in the cerebral circulation, originating
from even minor irregularities of the arterial wall, fibrillating atria, cardiac valves, and patent foramen ovale. Thrombus
fragments are globular and likely to completely obstruct terminal vessels. In contrast, previous work with “atheroemboli”
of needle-like cholesterol crystals rarely cause occlusions or infarctions instead creating small foci of inflammation. In this
work, we asked if microthrombi would occlude terminal vessels and create lacunar type infarctions in the subcortical
tissues of the rat brain where, as in human brain, collateral flow is limited relative to the cortex.
Methods: Three treatment groups of adult male Sprague-Dawley rats were studied. All groups underwent general
anesthesia with monitoring of temperature and blood pressure during cannulation of the right internal carotid artery. In
the group embolized with thrombus fragments (n  12), animals had injections of 300 fragments of thrombus size 60 to
100 microns, the cholesterol group (n  6 ) had injections of 300 cholesterol crystals of similar size, and the control group
(n  4) had injections of saline. Brains were harvested at 4 days with perfusion fixation and were examined by immunohis-
tochemical staining for breaks in the blood brain barrier (BBB) (albumin), microglial activation (CD11b), astrocyte activation
(GFAP), and infarction (loss of NeuN staining). Size and location of the areas of injury and infarction were recorded.
Results: Clot fragments caused discreet infarcts in 10/12 animals that were 0.1-1.7 mm in diameter and coincided with
activation of microglia and astrocytes. In some areas, necrosis was already underway at this early time point. Consistent
with our previous work, the infarcts caused by cholesterol crystals were smaller (P  .014). Foci of BBB disruption and
microglial activation were distributed throughout the brain whereas areas of infarction were found almost exclusively in
subcortical tissues (P  .029).
Conclusions: Injecting microthrombi reproducibly caused areas of necrosis resembling lacunar type infarctions. These
were primarily located in the striatum and thalamus presumably because these areas lack the branching, collateral network
seen in the cortex. In addition, these data give further evidence that the extent of brain injury from emboli depends upon
composition and shape as well as size. ( J Vasc Surg 2008;48:196-200.)Clinical Relevance: This model gives experimental support that microemboli are an etiologic agent of lacunar infarction.Lacunar infarcts are defined as small subcortical areas of
tissue loss resulting from occlusion of a single penetrating
artery.1 Current clinical/pathologic correlations are cred-
ited to C. M. Fisher who in a series of articles reported
findings from his own patients and refined concepts originally
set forth in the late 19th and early 20th century.2 Fisher
carefully examined human brain sections to trace single vessels
leading to areas of infarction that he believed correlated with
recorded clinical events. While there were classic atheromas in
a few vessels and some infarcts were attributed to emboli, the
majority, 40 of 50, were attributed to highly focal arterial
lesions occurring at branch points characterized by lipid dep-
osition, scarring, and modest vessel enlargement.3 Fisher
called these lesions “segmental arterial disorganization”, now
termed lipohyalinization. As 90% of the patients studied were
hypertensive,4 a causal effect was assumed and the “Lacunar
Hypothesis” proposed.
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196Fisher’s concepts on lacunar infarcts have been chal-
lenged over the ensuing decades. Diffuse thickening of
small cerebral vessels occurs with hypertension but segmen-
tal occlusions as Fisher described are rare,5,6 not found in
any other human organs and do not occur in hypertensive
animal models.7 Population studies of stroke have shown
that there is no greater prevalence or severity of hyperten-
sion among patients with lacunar infarction compared with
those with cortical stroke.8 In spite of these observations,
the Lacunar Hypothesis remains sacrosanct for many,9,10
seemingly because there is no clearly proven alternative
etiology.11,12 Authors looking for other etiologic agents
have suggested that emboli could be an important, if not
primary, cause of lacunar infarctions.7,8
Arguments against embolization causing lacunes in-
clude a presumed inability of emboli to access the penetrat-
ing arteries and the lack of a recognized embolic source in
many patients presenting with lacunar infarction. Neither
argument is particularly persuasive. Large emboli are un-
common in the small penetrating arteries, but emboli less
than 98 microns have equal access to both penetrating and
circumferential arteries of the primate brain.13 The lack of
an identified source does not rule out embolization. Even
stroke patients with multiple acute lesions on diffusion
weighted-magnetic resonance imaging (DW-MRI), a pat-
tern typical of embolization, may present without a clearly
identifiable embolic source.14,15 But the hypothesis that
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infarctions has not been tested. To this end we first com-
pared the effects from embolization of 60 to 100 micron
emboli formed from thrombus with those from cholesterol
crystals, another common component of atheroemboli;
then to determine whether 60 to 100 micron micro-
thrombi could cause small, discreet infarcts in subcortical
tissues similar to the lacunar type infarctions in humans.
METHODS
Surgery/emboli injection
Male Sprague Dawley rats weighing approximately 300
grams and fed a normal chow diet were injected with 300
microemboli sized 60 to 100 microns. The injections were
done into the right internal carotid artery as described previ-
ously.16 Twelve animals were injected with thrombus frag-
ments, six with cholesterol crystals, and four were sham oper-
ated controls. The procedure was done under isoflurane
anesthesia and was conducted as follows. The carotid bifurca-
tion was isolated from surrounding tissues and the common
carotid artery and the external carotid arteries were sur-
roundedwith 6-0 silk. After distal ligation, the external carotid
was cannulated and emboli injected in saline. The common
carotid was temporarily occluded as the emboli were injected.
The external carotid was then ligated proximally.
Microemboli preparation
Thrombus fragments. To provide uniformity of the
prepared fragments, homologous thrombus was used. Five
milliliters of homologous blood was drawn from the tail vein
of a donor animal. Blood clot was prepared as described by
Kudo.17 Briefly, blood was allowed to clot at room tempera-
ture and the serum removed. After the clot was minced
mechanically, it was passed through a series of filters. The
fragments that passed through a 100 micron mesh but were
filtered by the 60 micron mesh were resuspended in 3 ml of
saline and portions counted on a 100 micron grid at 100
magnification. The clot fragments were diluted to a final
concentration of 300 fragments per 300 L and injected
within 24 hours after the initial blood draw.
Cholesterol crystals. USP cholesterol crystals (Sigma
Chemical Co, St. Louis, Mo) were suspended in saline and
filtered as noted above. The crystals were also counted at
100 magnification and diluted to a final concentration of
300 crystals per 300 L of saline.
Tissue preparation and immunohistochemistry
To perform the brain sectioning and histologic analysis,
rats were euthanized and the brain processed as follows.
Under anesthesia, the aorta was cannulated. Each rat was
given heparin (100 U/Kg) and perfused with 200 ml of
0.9% saline, followed by 200 ml of 4.0% paraformaldehyde
in 0.1 M phosphate buffer, pH 7.4 (PBS). The brain was
removed from the cranial vault, and placed in 4% parafor-
maldehyde for 12 hours, PBS for 12 hours and 30% sucrose
for 2 days. Coronal free-floating sections 40 m thick were
cut and collected serially as described by Raber et al.18Immunohistochemistry was performed on every 12th sec-
tion (480 m apart) according to established protocol19
and examined for activated microglia (CD11b), activated
astrocytes (GFAP) albumin, and neuronal cell death
(NeuN) using the following reagents: mouse anti-NeuN (1
g/ml, Chemicon, Temecula, Calif); mouse anti-rat
CD11b (1 g/ml, Chemicon); mouse anti-GFAP (1 g/
ml, Chemicon); rabbit anti-albumin (Accurate Chemical
and Scientific Corp, Westbury, New York); biotinylated
sheep anti-mouse, anti-rabbit, and anti-rat secondary anti-
bodies (5 g/ml, Amersham, Cleveland, Ohio); ABC so-
lution (Vector laboratories, Burlingame, Calif); 0.05% dia-
minobenzine-tetrachloride (DAB Fast; Sigma, St. Louis,
Mo) with 0.01% H2O2 and 0.04% NiCl2 (Sigma); Strepta-
vidine Alexa Fluor 488 (Molecular Probes, Eugene, Ore).
Scoring of the brain injury
The entire brain was assessed to evaluate the extent of
injury or infarction and the location. The scoring criterion
used to assess injury caused by embolization was chosen to
offer a basis for comparisons between animals with small
areas of injury. Scoring was assigned as follows: 0: no
abnormality; 1: the diameter of injured or infarcted area
was less than 500 microns with no necrotic tissue. 2: the
diameter of injured or infarcted area was more than 500
microns or there was necrosis with a diameter of less than
500 microns; 3: the diameter of the areas of necrotic tissue
was more than 500 microns. Injury/infarction scores were
determined for the striatum, cortex, septum, hippocampus,
thalamus and corpus callosum separately with total scores
including all six areas. The scoring was done by consensus
of two non-blinded readers.
Statistical comparisons
The Mann Whitney rank sum test was used to compare
the median score of injury after the injection of thrombus
fragments with the extent of injury after injection of cho-
lesterol crystals. A comparison of proportions was used to
compare the distribution of lesions noted by CD11b stain-
ing vs the areas with a lack of NeuN staining.
RESULTS
General
No animals died as a result of the surgery and the carotid
injections. There were no limitations in motor function after
injection of either clot fragments or cholesterol crystals.
Immunohistochemistry of areas of injury
and infarction
Injection of thrombus fragments. After injection
with thrombus fragments, 10 of the 12 animals had at least
one area of infarction and only one animal had more than
three separate infarcts. The infarctions were small with
maximal diameters varying from less than 100 microns to
1.7mm in diameter (Table I, Fig 1). Using a scoring system
to quantitate the accumulated damage from small areas of
injury and infarction (Table I), the average infarction score
JOURNAL OF VASCULAR SURGERY
July 2008198 Rapp et alwas 2.25 1.60 (range 1-6). In eight of the animals, there
were areas of inflammation shown by microglial activation
(CD11b staining) in areas that did not have neuronal cell
death. The areas of injury were distributed in both the
cortical and subcortical regions while the infarctions almost
exclusively the striatum or the thalamus (Table II). GFAP
staining signaling astrocyte activation occurred less fre-
quently outside of infarct areas than microglial activation.
Albumin staining was not seen in areas of infarction (sug-
gesting a complete loss of perfusion), but was seen in areas
where there was injury only. In a few specimens after
injection of clot fragments, vessels in close proximity to
infarcts were observed to be occluded by thrombus (Fig 2).
Injection of cholesterol crystals. After the injection of
cholesterol crystals, only three of six animals had areas of
infarction and these were all smaller than 500 microns. These
represented significantly smaller areas of infarction compared
with thrombus fragments (P .014). Therewere several areas
of microglial activation and albumin staining (Fig 3) without
associated areas of infarct. No thrombosis was seen after
cholesterol crystal embolization. There was no evidence of
injury in the saline injected animals.
Location of injury and infarction after the injection of
thrombus fragments (Table II)
After the injection of thrombus fragments, areas of
microglial activation, signifying either injury or infarction
were distribution throughout the brain. In contrast, areas
Table I. Brain Injury assessed by immunostaining after
injection of 300 sized 60 to 100 micron clot fragments or
cholesterol crystals in rats
Sham
Thrombus
Fragment
Cholesterol
crystal
Animals Studied 4 12 6
CD11b staininga 0 11 4
Score (total)b 0 44 11
Average scorec 0 3.67  2.27 1.83  1.94
NeuN stain lossa 0 10 3
Score (total)b 0 27 3
Average scorec 0 2.25  1.60 0.5  0.55*
GFAP staininga 0 9 3
Score (total)b 0 20 4
Average scorec 0 1.64  1.29 0.67  0.82
Albumin staininga 0 4 4
Score (total)b 0 6 5
Average scorec 0 0.55  0.82 0.83  0.75
*p  0.014 comparing area of infarction caused by thrombus fragments
versus cholesterol crystals.
aKey: CD11b stain shows activated microglia, NeuN stain loss indicates loss
of neurons, GFAP staining shows activated astrocytes.
bScoring criteria: 0: no infarct or injury staining; 1: the diameter of injury/
infarction area is less than 500 microns with no necrotic tissue; 2: the diameter
of injured/infarcted area is more than 500 microns or the diameter of necrotic
tissue less than 500 microns; 3: the diameter of necrotic tissue area more than
500microns. The score was determined in striatum, cortex, septum, hippocam-
pus, thalamus, and corpus collosum separately. Total scores include all above six
areas, the maximum total score in one animal was 18.
cAverage score was shown with mean  SD.lacking staining with NeuN, signifying infarction, werefound exclusively in the subcortex particularly the striatum
and thalamus (P  .029) (Table II). No such trend oc-
Fig 1. Three photomicrografts of immunohistochemistry stain-
ing of an area of infarction after injection of microthrombi.
A, Infarction indicated by a lack of neuronal cell death (NeuN)
staining. B, Activated microglia shown with staining for activated
microglia (CD11b). C, Activated astrocytes (GFAP) staining
showing activation of astrocytes in the area.curred after the injection of cholesterol crystals.
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We compared the ischemic injury caused by embolization
of thrombus fragments sized 60 to 100 microns with that
caused by similarly sized cholesterol crystals in the rat. Areas of
infarction were more frequent, larger, and more likely to
include frank necrosis after injection of thrombus fragments
(injury score 2.25  1.60 vs 0.50  0.55, P  .014). Vessel
occlusions were seen with thrombus injection, but not after
the injection of cholesterol emboli, whichmay reduce flow by
transient vessel constriction around the crystals.20 Both em-
bolic materials caused foci of injury more frequently than
infarction. These were characterized by albumin leakage and
focal activation of microglia.
In these experiments, the size of emboli injected was
limited to those that would be equally distributed through-
out the primate brain. The number was chosen to compare
thrombus fragments with current and previous work on
embolization of cholesterol crystals.21 Homologous blood
from a single animal was used to ensure a uniform prepara-
tion of thrombus fragments. While this could have caused
an immune response even at this early time point, the injury
Table II. Location of infarction and injurya
Thrombus
fragments Cholesterol crystals
NeuNb CD11b NeuN CD11b
Cortex 0 7 1 2
Subcortex (total) 27 37 2 9
Striatum 9 10 0 3
Thalamus 16 19 1 3
Septum 0 0 0 0
Hippocampus 0 6 1 3
Corpus collosum 2 2 0 0
NeuN, neuronal cell death; CD11b, activated microglia.
aUsing the scoring system described in Methods and in Table I.
bP .029 for the proportion of cortical infarcts compared with the propor-
tion of cortical injuries.
Fig 2. Intraluminal thrombus in vessel leading to an area of
infarction after injection of microthrombi.caused by the globular thrombus fragments is consistentwith our previous results after the injection of micro-
spheres,16 suggesting that the use of homologous blood
did not substantively changed our results. We are not the
first to inject homologous thrombus fragments into the rat
brain. Kudo and colleagues developed the model but did
not count or limit fragment size, which was reported to
have had a mean of 200 to 300 microns.17,22,23 Their
preparation created large areas of infarction and reduced
total blood flow to the brain. Futrell et al created platelet
thrombi by producing a photochemical injury to the rat
internal carotid artery. Like the Kudo clot fragment model,
the number and size of emboli created was not deter-
mined,24 but this model did create multiple small lacunar
type infarctions.
In the current study, we injected 300 thrombus frag-
ments into the two gram rat brain and created an average of
two to three lesions per animal. This resembles the clinical
situation, where, over time, hundreds, if not thousands, of
microemboli may enter the cerebral circulation 25 without
causing apparent injury. We suspect that particulates that
did not create infarctions either marginated and became
adherent to the vessel wall, or lodged in arteries where the
distal tissue had adequate collateral flow. However, the fate
of these silent emboli is unknown. Perhaps they underwent
thrombolysis or in the case of cholesterol crystals, mobili-
zation or absorption.
The infarctions after injection of thrombus fragments
occurred exclusively in the subcortex (P  .001). Lacunar
type infarctions seen in humans are also predominantly limited
to the subcortical tissues but account for one-quarter to one-
third of all ischemic strokes.26,27 The rat striatum’s known
susceptibility to ischemic injury compared with the cortex is
thought to reflect greater branching and collateralization of
the vessels within the cortex.28,29 Data from examinations of
human brain microvascular architecture reflect a similar
Fig 3. Two vessels with circumferential perivascular staining for
albumin indicating disruption of the blood brain barrier after
injection of cholesterol crystals.disparity of potential collateralization between the cortex
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brains, noted reduced branching in the subcortical pene-
trating arteries compared with cortical arteries.3 This find-
ing has been confirmed by microscopic examinations of
human brain vascular casts.30 Furthermore, with aging,
arteries of the subcortex are susceptible to coiling of the
lumen within the adventitial space.31 Vessels of the cortex
are not affected. Coiling appears to begin in middle age and
while initial studies have not shown a correlation of coiling
with white mater disease,32 these abnormal vessels may be
more susceptible to occlusion by microemboli.31
Our work using homologous thrombus fragments in
rats does not prove that lacunar infarcts in humans are due
to microemboli. However, it does add to the evidence
indicating that microemboli could have an etiologic role.
The vulnerability of the rat subcortex to ischemic injury
from microemboli make this an excellent model for further
study of the role of emboli in lacunar infarction and other
manifestations of what has been thought to be intrinsic
small vessel disease of the brain.
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